UNIVERSITY OF ROCHESTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1850-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.rochester.edu
Preventing Squamous Cell Skin Cancer
- First Posted Date
- 2015-01-27
- Last Posted Date
- 2020-06-23
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 12
- Registration Number
- NCT02347813
Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer
Not Applicable
Completed
- Conditions
- Pancreatic CancerAdenocarcinoma
- Interventions
- Radiation: Preoperative SBRT
- First Posted Date
- 2015-01-27
- Last Posted Date
- 2022-07-18
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 18
- Registration Number
- NCT02347618
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
Devel. and Eval. of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate Cancer
Not Applicable
Completed
- Conditions
- Adenocarcinoma of Prostate
- Interventions
- Behavioral: Dashboard
- First Posted Date
- 2015-01-21
- Last Posted Date
- 2018-01-09
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 140
- Registration Number
- NCT02342626
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
TTE and Dysphagia in Anterior Cervical Surgery
Not Applicable
Completed
- Conditions
- Dysphagia
- Interventions
- Other: Trachael Preparation Education
- First Posted Date
- 2014-12-25
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 150
- Registration Number
- NCT02326116
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Evaluation of Ocular Surface Inflammatory Mediators Effected by Lotemax
Not Applicable
Completed
- Conditions
- Sjogren's Disease
- Interventions
- Drug: Administration of Lotemax
- First Posted Date
- 2014-12-23
- Last Posted Date
- 2015-10-16
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 10
- Registration Number
- NCT02322528
- Locations
- 🇺🇸
Flaum Eye Institute at the University of Rochester, Rochester, New York, United States
Multicenter Observational Study of Myotonic Dystrophy Type 1
Completed
- Conditions
- Myotonic Dystrophy Type 1
- First Posted Date
- 2014-12-04
- Last Posted Date
- 2017-10-26
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 120
- Registration Number
- NCT02308657
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸Stanford University, Stanford, California, United States
🇺🇸University of Rochester, Rochester, New York, United States
The Leaky Lung Test
Early Phase 1
Completed
- Conditions
- AllergyAsthmaReactive Airway DiseaseLung Diseases, Obstructive
- Interventions
- First Posted Date
- 2014-12-03
- Last Posted Date
- 2018-01-04
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 100
- Registration Number
- NCT02306473
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
Peer Led Asthma Self Management for Adolescents: PLASMA
Phase 2
Completed
- Conditions
- Asthma
- Interventions
- Behavioral: PLASMA
- First Posted Date
- 2014-11-18
- Last Posted Date
- 2021-04-08
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 371
- Registration Number
- NCT02293499
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸University at Buffalo, Buffalo, New York, United States
🇺🇸University of Rochester Medical Center, Rochester, New York, United States
Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy
Not Applicable
Terminated
- Conditions
- Clostridium DifficileProstate CancerUrinary Tract Infection
- Interventions
- First Posted Date
- 2014-09-25
- Last Posted Date
- 2017-04-17
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 175
- Registration Number
- NCT02247960
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
Safety and Feasibility Study of Methylene Blue Photodynamic Therapy to Sterilize Deep Tissue Abscess Cavities
Phase 1
Completed
- Conditions
- Abscess
- Interventions
- Drug: 20% I.V. Fat EmulsionDevice: Insertion of optical fiberDevice: Laser illumination, 5 minutesDevice: Laser illumination, 10 minutesDevice: Laser illumination, 15 minutesDevice: Laser illumination, 20 minutesDevice: Laser illumination, 25 minutesDevice: Laser illumination, 30 minutesDevice: Optical spectroscopy measurement
- First Posted Date
- 2014-09-15
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 21
- Registration Number
- NCT02240498
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
© Copyright 2025. All Rights Reserved by MedPath